Joint Diseases  >>  MK 0873  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MK 0873 / Merck (MSD)
NCT00132769: A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)

Completed
2
106
Canada
MK-0873, Comparator: Placebo
Merck Sharp & Dohme LLC
Rheumatoid Arthritis
11/05
11/05

Download Options